Share This Page
Drug Price Trends for NDC 31722-0506
✉ Email this page to a colleague
Average Pharmacy Cost for 31722-0506
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LAMIVUDINE-ZIDOVUDINE TABLET | 31722-0506-60 | 0.60082 | EACH | 2024-12-18 |
| LAMIVUDINE-ZIDOVUDINE TABLET | 31722-0506-60 | 0.62051 | EACH | 2024-11-20 |
| LAMIVUDINE-ZIDOVUDINE TABLET | 31722-0506-60 | 0.64462 | EACH | 2024-10-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 31722-0506
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
31722-0506 Market Analysis and Financial Projection
Market Analysis and Price Projections for NDC: 31722-0506 (Lamivudine and Zidovudine)
Introduction
The pharmaceutical market is a complex and dynamic sector, influenced by various factors including regulatory changes, patent expirations, and market competition. This article focuses on the market analysis and price projections for the drug identified by the National Drug Code (NDC) 31722-0506, which is Lamivudine and Zidovudine, manufactured by Camber Pharmaceuticals, Inc.
Overview of Lamivudine and Zidovudine
Lamivudine and Zidovudine is a combination antiretroviral medication used in the treatment of HIV/AIDS. It combines two nucleoside reverse transcriptase inhibitors (NRTIs) that work together to inhibit the replication of the HIV virus.
Market Trends in the Pharmaceutical Industry
Global Pharmaceutical Market Outlook
The global pharmaceutical market is projected to reach $1.7 trillion by 2030, with a growth rate of 7.7% driven by a shift towards treating major diseases such as obesity and other metabolic disorders[4].
Impact of Generic Drugs
Generic drugs, like Lamivudine and Zidovudine, play a significant role in the pharmaceutical market. The competition from generic drugs and biosimilars is a top trend, with 37% of life sciences executives viewing it as a key factor affecting their strategies[3].
Pricing Dynamics
Price Transparency and Regulation
The pricing of prescription drugs, including generics, is under increasing scrutiny. Reports from drug price transparency programs highlight significant price increases for some generic drugs. For instance, a generic version of naproxen saw a 2,527% price increase between 2012 and 2021[2].
Pricing of Lamivudine and Zidovudine
As a generic medication, the pricing of Lamivudine and Zidovudine is generally more stable compared to brand-name drugs. However, prices can fluctuate based on market demand, production costs, and regulatory changes. Given its status as a generic, it is less likely to experience the dramatic price increases seen in some other generic drugs.
Competitive Landscape
Camber Pharmaceuticals, Inc.
Camber Pharmaceuticals, Inc. is a significant player in the generic drug market, offering a wide range of medications, including Lamivudine and Zidovudine. The company's portfolio includes various NDCs for different formulations and strengths of this combination drug[1][5].
Market Competition
The market for antiretroviral medications is competitive, with multiple manufacturers producing generic versions of Lamivudine and Zidovudine. This competition helps keep prices relatively stable and accessible to patients.
Regulatory Environment
Patent Expirations and Generic Entry
The life sciences industry is facing a substantial loss of exclusivity due to expiring patents on high-revenue products. This trend is expected to drive interest in mergers and acquisitions and increase the entry of generic drugs into the market[3].
Regulatory Compliance
Manufacturers like Camber Pharmaceuticals must comply with stringent regulatory requirements to ensure the quality and safety of their products. This includes adhering to FDA guidelines and reporting any price changes or other relevant information.
Price Projections
Short-Term Projections
Given the stable nature of generic drug pricing, it is unlikely that Lamivudine and Zidovudine will experience significant price increases in the short term. The median price increase for generic drugs reported in recent years has been around 19.9%, but this is not expected to be uniform across all generic medications[2].
Long-Term Projections
In the long term, the pricing of Lamivudine and Zidovudine is expected to remain relatively stable. However, factors such as changes in raw material costs, manufacturing efficiencies, and market demand could influence prices. The overall trend in the pharmaceutical industry suggests that generic drugs will continue to be a cost-effective option for patients.
Technological and Innovative Trends
Digital Transformation and Personalized Medicine
The life sciences industry is undergoing significant transformation driven by digital advancements and scientific innovations. While these trends are more pronounced in the development of new therapies, they also impact the manufacturing and distribution of existing generic medications. Improved operational efficiencies and the use of technologies like gen AI can help reduce costs and enhance patient outcomes[3].
Patient Access and Affordability
Pricing and Access Issues
Pricing and access to drugs remain significant issues in the life sciences industry. Nearly half of C-suite executives surveyed expect pricing and access to significantly affect their strategies in 2025. This underscores the need for affordable medications like Lamivudine and Zidovudine to remain accessible to patients[3].
Conclusion
The market for Lamivudine and Zidovudine, identified by NDC 31722-0506, is influenced by a combination of factors including market competition, regulatory compliance, and technological advancements. Here are some key takeaways:
- Stable Pricing: Generic drugs like Lamivudine and Zidovudine are expected to maintain relatively stable prices due to market competition.
- Regulatory Compliance: Manufacturers must adhere to stringent regulatory requirements to ensure product quality and safety.
- Technological Advancements: Digital transformation and innovations in the life sciences industry can improve operational efficiencies and patient outcomes.
- Patient Access: Ensuring affordable access to medications remains a critical issue in the pharmaceutical industry.
Key Takeaways
- The global pharmaceutical market is projected to grow significantly by 2030.
- Generic drugs, including Lamivudine and Zidovudine, play a crucial role in the market.
- Pricing stability is expected for generic medications due to market competition.
- Regulatory compliance is essential for maintaining product quality and safety.
- Technological advancements can enhance operational efficiencies and patient outcomes.
FAQs
Q: What is the NDC 31722-0506 used for? A: The NDC 31722-0506 is for Lamivudine and Zidovudine, a combination antiretroviral medication used in the treatment of HIV/AIDS.
Q: Who manufactures NDC 31722-0506? A: Camber Pharmaceuticals, Inc. manufactures this medication.
Q: What are the key factors influencing the pricing of generic drugs? A: Market competition, regulatory changes, and production costs are key factors influencing the pricing of generic drugs.
Q: How does the regulatory environment impact the pricing of Lamivudine and Zidovudine? A: The regulatory environment ensures compliance with safety and quality standards, which can influence pricing through reporting requirements and regulatory approvals.
Q: What are the long-term price projections for Lamivudine and Zidovudine? A: Long-term price projections suggest that the pricing of Lamivudine and Zidovudine will remain relatively stable, influenced by factors such as raw material costs and market demand.
Sources
- Find a Code: Camber Pharmaceuticals, Inc. - List of Drugs - NDC Labeler/Manufacturer.
- Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations.
- Deloitte Insights: 2025 life sciences outlook.
- Evaluate: Evaluate Releases 2030 Forecasts for Global Pharmaceutical Market.
- Find a Code: Camber Pharmaceuticals - List of Drugs - NDC Labeler/Manufacturer.
More… ↓
